Shandong Pharmaceutical Glass CoSHSE:600529 +2.01%83 Operating Margin % is 22.05% as of Mar. 2026, which is 18% above its 10-year median of 18.63. GuruFocus rates SHSE:600529 with a GF Score™ of 83/100 and a GF Value™ of ¥23.98 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 389 Packaging & Containers companies, Shandong Pharmaceutical Glass Co ranks better than 96.14% on this metric.
Shandong Pharmaceutical Glass Co Ltd operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Shandong Pharmaceutical Glass Co's Operating Margin % or its related term are showing as below:
SHSE:600529'
s Operating Margin % Range Over the Past 10 Years
Min: 14.23 Med: 18.63 Max: 22.44
Current: 21.17
SHSE:600529's Operating Margin % is ranked better than 96.14% of 389
companies
in the Packaging & Containers industry
Industry Median: 5.27
vs SHSE:600529: 21.17
Shandong Pharmaceutical Glass Co (SHSE:600529) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Shandong Pharmaceutical Glass Co Operating Margin % Related Terms
Shandong Pharmaceutical Glass Co Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co Operating Margin % Chart
SHSE:600529 vs SW, PKG, IP: Operating Margin % Comparison
For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Pharmaceutical Glass Co Operating Margin % vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Shandong Pharmaceutical Glass Co's Operating Margin % falls into.
Shandong Pharmaceutical Glass Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co (SHSE:600529) has a Operating Margin % of 22.05% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Shandong Pharmaceutical Glass Co and its competitors. This is 18% above median its historical median of 18.63. Over the past decade, Shandong Pharmaceutical Glass Co's Operating Margin % has ranged from 14.23 to 22.44. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #15 out of 389 companies in the Packaging & Containers industry, placing it in the top 3.9%.
Is Shandong Pharmaceutical Glass Co's Operating Margin % too high?
Shandong Pharmaceutical Glass Co's current Operating Margin % of 22.05% is 18% above median its 10-year median of 18.63. Over the past 10 years, this metric has ranged from a low of 14.23 to a high of 22.44. The Packaging & Containers industry median Operating Margin % is 5.27. Shandong Pharmaceutical Glass Co's value of 22.05% is 318.4% above this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #15 out of 389 companies in the Packaging & Containers industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's Operating Margin % compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #15 out of 389 companies for Operating Margin %. This places Shandong Pharmaceutical Glass Co in the top 4% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 5.27. Shandong Pharmaceutical Glass Co's value of 22.05% is 318.4% above this benchmark. Historically, Shandong Pharmaceutical Glass Co's own Operating Margin % has ranged from 14.23 to 22.44 over the past decade. While the company's 10-year median is 18.63 vs. the industry median of 5.27, Shandong Pharmaceutical Glass Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Packaging & Containers company?
The median Operating Margin % among Packaging & Containers companies is 5.27, based on 389 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current Operating Margin % of 22.05% is 318.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Shandong Pharmaceutical Glass Co and its competitors. For the Packaging & Containers industry, the median Operating Margin % is 5.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current Operating Margin % is 22.05%, which is 18% above median its own 10-year median of 18.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.98, compared to a current price of ¥18.29 — trading 23.7% below its estimated fair value. The current Operating Margin % is 22.05%, which is 18% above median its 10-year median of 18.63 and 318.4% above the Packaging & Containers industry median of 5.27. Shandong Pharmaceutical Glass Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current Operating Margin % is 22.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥18.29 is trading 23.7% below its estimated GF Value™ of ¥23.98.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
Operating Margin %: 22.05% (18% above median its 10-year median of 18.63)
GF Value™: ¥23.98 vs. price of ¥18.29 (23.7% below fair value)
Industry Position: 318.4% above the Packaging & Containers median (#15 of 389)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Business Description
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
83GF Score
Get the complete analysis for SHSE:600529
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
